本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Elevation Oncology, Inc.

0.3650
0.0000
成交量:- -
成交額:175.06萬
市值:2,162.73萬
市盈率:-0.45
高:0.3650
開:0.3650
低:0.3650
收:0.3650
52周最高:3.09
52周最低:0.2210
股本:5,925.29萬
流通股本:4,353.48萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8118
每股收益(LYR):-0.7767
淨資產收益率:-78.32%
總資產收益率:-29.86%
市淨率:0.46
市盈率(LYR):-0.47

資料載入中...

2022/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/03

重要事件披露

8-K - Current report
2022/03/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K - Current report
2022/01/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/21

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/21

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/23

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933